Abstract
CD137 is a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Interaction of CD137 with its ligand (CD137L) affects the apoptosis, proliferation and differentiation of immune cells. Interestingly, the CD137 receptor/ligand system involves the bi-directional transduction of signals. The expression of CD137 and its ligand is not restricted to immune organs, but can also be detected in a wide variety of tissues such as the brain, kidney, lung and heart. However, its role in brain is largely unknown. This study was performed to determine the role of CD137L reverse signaling in the apoptosis of neural stem cells. We identified the expression of CD137 and its ligand in C17.2 neural stem cells derived from mouse embryonic cerebellum. We found that the activation of CD137L reverse signaling by CD137 resulted in a decrease in cell adhesion to the fibronectin-coated culture basement, thus causing detachment-induced cell death. Furthermore, we showed that the cell death induced by CD137 was completely ameliorated by integrin activators and caspase inhibitors. Therefore we suggest that CD137L reverse signaling exerts a pro-apoptotic effect by suppressing integrin-mediated survival signals in neural stem cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almeida, E.A., Ilic, D., Han, Q., Hauck, C.R., Jin, F., Kawakatsu, H., Schlaepfer, D.D., and Damsky, C.H. (2000). Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. 149, 741–754.
Boudreau, N.J., and Jones, P.L. (1999). Extracellular matrix and integrin signalling: the shape of things to come. Biochem. J. 339(Pt 3), 481–488.
Bozzo, C., Sabbatini, M., Tiberio, R., Piffanelli, V., Santoro, C., and Cannas, M. (2006). Activation of caspase-8 triggers anoikis in human neuroblastoma cells. Neurosci. Res. 56, 145–153.
Campos, L.S. (2005). Beta1 integrins and neural stem cells: making sense of the extracellular environment. Bioessays 27, 698–707.
Ceccatelli, S., Tamm, C., Sleeper, E., and Orrenius, S. (2004). Neural stem cells and cell death. Toxicol. Lett. 149, 59–66.
Cory, S., and Adams, J.M. (2005). Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell 8, 5–6.
Croft, M. (2003). Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3, 609–620.
Frisch, S.M., and Screaton, R.A. (2001). Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555–562.
Grossmann, J. (2002). Molecular mechanisms of “detachmentinduced apoptosis—Anoikis”. Apoptosis 7, 247–260.
Gullo, C., Koh, L.K., Pang, W.L., Ho, K.T., Tan, S.H., and Schwarz, H. (2010). Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling. PLoS One 5, e10845.
Haupt, S., Berger, M., Goldberg, Z., and Haupt, Y. (2003). Apoptosis — the p53 network. J. Cell. Sci. 116, 4077–4085.
Hu, P., and Luo, B.H. (2012). Integrin bi-directional signaling across the plasma membrane. J. Cell. Physiol. 228, 306–312.
Ilic, D., Almeida, E.A., Schlaepfer, D.D., Dazin, P., Aizawa, S., and Damsky, C.H. (1998). Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547–560.
Janes, S.M., and Watt, F.M. (2004). Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J. Cell Biol. 166, 419–431.
Jiang, D., Chen, Y., and Schwarz, H. (2008). CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages. J. Immunol. 181, 3923–3932.
Jin, S., and Levine, A.J. (2001). The p53 functional circuit. J. Cell. Sci. 114, 4139–4140.
Kim, M.S., Hur, M.K., Son, Y.J., Park, J.I., Chun, S.Y., D’Elia, A.V., Damante, G., Cho, S., Kim, K., and Lee, B.J. (2002). Regulation of pituitary adenylate cyclase-activating polypeptide gene transcription by TTF-1, a homeodomain-containing transcription factor. J. Biol. Chem. 277, 36863–36871.
Kokovay, E., Shen, Q., and Temple, S. (2008). The incredible elastic brain: how neural stem cells expand our minds. Neuron 60, 420–429.
Kriegstein, A., and Alvarez-Buylla, A. (2009). The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 32, 149–184.
Kwon, B.S., Kim, G.S., Prystowsky, M.B., Lancki, D.W., Sabath, D.E., Pan, J.L., and Weissman, S.M. (1987). Isolation and initial characterization of multiple species of T-lymphocyte subset cDNA clones. Proc. Natl. Acad. Sci. USA 84, 2896–2900.
Kwon, B., Moon, C.H., Kang, S., Seo, S.K., and Kwon, B.S. (2000). 4-1BB: still in the midst of darkness. Mol. Cells 10, 119–126.
Langstein, J., Michel, J., Fritsche, J., Kreutz, M., Andreesen, R., and Schwarz, H. (1998). CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160, 2488–2494.
Massirer, K.B., Carromeu, C., Griesi-Oliveira, K., and Muotri, A.R. (2011). Maintenance and differentiation of neural stem cells. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 107–114.
Melero, I., Shuford, W.W., Newby, S.A., Aruffo, A., Ledbetter, J.A., Hellstrom, K.E., Mittler, R.S., and Chen, L. (1997). Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3, 682–685.
Molofsky, A.V., Pardal, R., and Morrison, S.J. (2004). Diverse mechanisms regulate stem cell self-renewal. Curr. Opin. Cell Biol. 16, 700–707.
Mould, A.P., Akiyama, S.K., and Humphries, M.J. (1995). Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J. Biol. Chem. 270, 26270–26277.
Ni, H., Li, A., Simonsen, N., and Wilkins, J.A. (1998). Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain. J. Biol. Chem. 273, 7981–7987.
Nicholson, D.W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028–1042.
Park, S.J., Kim, H.J., Lee, J.S., Cho, H.R., and Kwon, B. (2012). Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation. Mol. Cells 33, 533–537.
Pollok, K.E., Kim, Y.J., Zhou, Z., Hurtado, J., Kim, K.K., Pickard, R.T., and Kwon, B.S. (1993). Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150, 771–781.
Reali, C., Curto, M., Sogos, V., Scintu, F., Pauly, S., Schwarz, H., and Gremo, F. (2003). Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2. J. Neurosci. Res. 74, 67–73
Saito, K., Ohara, N., Hotokezaka, H., Fukumoto, S., Yuasa, K., Naito, M., Fujiwara, T., and Nakayama, K. (2004). Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J. Biol. Chem. 279, 13555–13563.
Schwarz, H., Valbracht, J., Tuckwell, J., von Kempis, J., and Lotz, M. (1995). ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85, 1043–1052.
Senthilkumar, R., and Lee, H.W. (2009). CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation. Immunobiology 214, 153–161.
Shao, Z., and Schwarz, H. (2011). CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J. Leukoc. Biol. 89, 21–29.
Shuford, W.W., Klussman, K., Tritchler, D.D., Loo, D.T., Chalupny, J., Siadak, A.W., Brown, T.J., Emswiler, J., Raecho, H., Larsen, C.P., et al. (1997). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186, 47–55.
Snyder, E.Y., Deitcher, D.L., Walsh, C., Arnold-Aldea, S., Hartwieg, E.A., and Cepko, C.L. (1992). Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68, 33–51.
Stuiver, I., and O’Toole, T.E. (1995). Regulation of integrin function and cellular adhesion. Stem Cells 13, 250–262.
Stupack, D.G., and Cheresh, D.A. (2002). Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115, 3729–3738.
Tate, M.C., Shear, D.A., Hoffman, S.W., Stein, D.G., Archer, D.R., and LaPlaca, M.C. (2002). Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant. 11, 283–295.
Thorburn, A. (2004). Death receptor-induced cell killing. Cell. Signal. 16, 139–144.
Wu, C., Keivens, V.M., O’Toole, T.E., McDonald, J.A., and Ginsberg, M.H. (1995). Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 83, 715–724.
Xia, H., Nho, R.S., Kahm, J., Kleidon, J., and Henke, C.A. (2004). Focal adhesion kinase is upstream of phosphatidylinositol — kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J. Biol. Chem. 279, 33024–33034.
Yeo, Y.A., Martinez Gomez, J.M., Croxford, J.L., Gasser, S., Ling, E.A., and Schwarz, H. (2012). CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species. J. Neuroinflammation 9, 173.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yun, C.H., Lee, H.M., Lee, S.C. et al. Involvement of CD137 ligand signaling in neural stem cell death. Mol Cells 36, 245–251 (2013). https://doi.org/10.1007/s10059-013-0137-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-013-0137-3